Clinical Trials · NCT02730377
Efficacy in Controlling Glycaemia With Victoza® (Liraglutide) as add-on to Metformin vs. OADs as add-on to Metformin After up to 104 Weeks of Treatment in Subjects With Type 2 Diabetes
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 1,991
- Start date
- Mar 2016
- Locations
- 232 sites, 10 countries
- Primary endpoint
- Time to Inadequate Glycaemic Control